Trepicchio, C. | Search bioRxiv

bioRxiv2023

Advancements in Human Breast Organoid Culture: Modeling Complex Tissue Structures and Developmental Insights

Organoids have emerged as a powerful tool for modeling tissue growth and diseases. In this study, we introduce a groundbreaking organotypic culture technique that replicates the morphology, scale, and heterogeneity of human breast tissue, and includes a mesenchymal-like stromal component. A standout feature of this approach is the use of long-term live imaging at high temporal resolution to directly observe stem cell dynamics during organogenesis, from single cells to mature organ tissue. The system is adaptable for high throughput applications and allows for genetic manipulation of the cells. Real-time imaging of ex-vivo tissue formation reveals a non-canonical process of ductal-lobular morphogenesis and branching, and de-novo generation of a supportive stroma. Incorporating patient-derived single cells from multiple donors offers an enhanced representation of the spectrum of individual responses and the impacts of distinct exposures. While developed for breast tissue, the principles of this technology can serve as a model for the development of similar systems in other tissues, where organoids do not merely reproduce the tissue, but where their regeneration can also be observed and studied. In addition, this model provides a quantitative experimental system to study mechanisms of embryogenesis, development, and tissue organization where biomechanics plays an important role.

developmental biology↗

bioRxiv2023

Selective inhibition of fibroblast-specific Domain Discoidin Receptor 1 (DDR1) reduces collagen deposition and modulates fibroblast-specific cytokine release within the breast microenvironment.

Fibroblasts are a major cell type within breast microenvironment which play key roles in tissue remodeling during the processes of normal development, injury, and malignancy. During wound healing and tumorigenesis, fibroblasts facilitate production and degradation of the extracellular matrix and produce inflammatory mediators which act as immune regulators. Domain Discoidin Receptor 1 (DDR1) is a cell surface tyrosine kinase receptor expressed by epithelial and stromal cells which is activated by collagen. In the breast, DDR1 expression and activity has been implicated in the development of fibrosis as well as chemotherapy resistance. We set out to examine whether selective inhibition of DDR1 would modulate fibroblast immunomodulatory function to generate an immune-permissive breast microenvironment and reduce stromal desmoplasia. In vivo, DDR1 inhibition resulted in mammary fibroblast tissue remodeling, reduced collagen deposition, and changes in immunomodulatory cytokine expression. Furthermore, DDR1 inhibition was associated with increased CD45.2+ immune cell infiltration and reduced Ly6G+/Ly6C- neutrophil infiltration. Mechanistically, we developed an ex-vivo 3D collagen hydrogel model of desmoplasia to study the effects of DDR1 inhibition on the expression of immune modulating factors and fibroblast functions and features. We found that DDR1 regulates the expression and secretion of key immunomodulatory cytokines (IL-6, IL-8, and MCP-1). Collectively these findings suggest that breast fibroblast-specific DDR1 mediates collagen deposition and immunomodulatory function within the mammary gland and warrants further investigation as a potential target for fibroblast-modulating therapy in benign and neoplastic breast disorders.

cell biology↗